Q32 Bio Inc (QTTB) concluded trading on Thursday at a closing price of $3.32, with 59.6 million shares of worth about $197.87 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.29% during that period and on July 10, 2025 the price saw a gain of about 119.87%. Currently the company’s common shares owned by public are about 12.20M shares, out of which, 4.44M shares are available for trading.
Stock saw a price change of 130.56% in past 5 days and over the past one month there was a price change of 82.42%. Year-to-date (YTD), QTTB shares are showing a performance of -82.53% which decreased to -3.49% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.35 but also hit the highest price of $53.79 during that period. The average intraday trading volume for Q32 Bio Inc shares is 1.12 million. The stock is currently trading 103.77% above its 20-day simple moving average (SMA20), while that difference is up 98.21% for SMA50 and it goes to -74.63% lower than SMA200.
Q32 Bio Inc (NASDAQ: QTTB) currently have 12.20M outstanding shares and institutions hold larger chunk of about 19.06% of that.
The stock has a current market capitalization of $40.50M and its 3Y-monthly beta is at -0.03. It has posted earnings per share of -$4.95 in the same period. It has Quick Ratio of 4.71. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for QTTB, volatility over the week remained 33.64% while standing at 13.63% over the month.
Stock’s fiscal year EPS is expected to rise by 47.27% while it is estimated to decrease by -27.66% in next year. EPS is likely to shrink at an annualized rate of 4.80% for next 5-years, compared to annual growth of 31.75% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on February 11, 2025 offering a Neutral rating for the stock and assigned a target price range of between $20 and $4 to it. Coverage by BMO Capital Markets stated Q32 Bio Inc (QTTB) stock as a Market perform in their note to investors on February 11, 2025, suggesting a price target of $3 for the stock. On December 11, 2024, Wells Fargo Downgrade their recommendations, while on December 11, 2024, Raymond James Downgrade their ratings for the stock with a price target of $22. Stock get a Market perform rating from Leerink Partners on December 11, 2024.
